| scholarly article | Q13442814 |
| P50 | author | Trinidad Montero-Melendez | Q44687257 |
| Maria Pini | Q57338856 | ||
| Mauro Perretti | Q60976463 | ||
| P2093 | author name string | Dianne Cooper | |
| Giamila Fantuzzi | |||
| Karla J Castellanos | |||
| Davina H Rhodes | |||
| P2860 | cites work | Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity | Q24291399 |
| Galectin-1 research in T cell immunity: past, present and future | Q26825120 | ||
| Galectins: structure, function and therapeutic potential | Q28283659 | ||
| Tim3 binding to galectin-9 stimulates antimicrobial immunity | Q28505971 | ||
| Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines | Q28513990 | ||
| Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients | Q28566479 | ||
| The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin | Q28585701 | ||
| Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake | Q30157218 | ||
| Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice | Q33832505 | ||
| Suppression of autoimmune diabetes by soluble galectin-1 | Q34087128 | ||
| Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. | Q34755698 | ||
| Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice | Q35558651 | ||
| Adipose tissue, adipokines, and inflammation | Q36114223 | ||
| Abdominal adiposity and cardiometabolic risk: do we have all the answers? | Q36919465 | ||
| Adiponectin and inflammation: consensus and controversy | Q37025392 | ||
| Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals | Q37072370 | ||
| Endogenous galectins and the control of the host inflammatory response | Q37373062 | ||
| Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue | Q37597597 | ||
| TIM-3 as a new therapeutic target in systemic lupus erythematosus. | Q37600707 | ||
| Multiple functional targets of the immunoregulatory activity of galectin-1: Control of immune cell trafficking, dendritic cell physiology, and T-cell fate. | Q37785133 | ||
| Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells | Q39657596 | ||
| Epigenetic maturation in colonic mucosa continues beyond infancy in mice | Q40392338 | ||
| Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor | Q42467384 | ||
| Negative regulation of adipose-expressed galectin-12 by isoproterenol, tumor necrosis factor alpha, insulin and dexamethasone | Q42809603 | ||
| Galectin-12 is required for adipogenic signaling and adipocyte differentiation | Q42829168 | ||
| Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes | Q43191933 | ||
| Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice | Q43407813 | ||
| Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. | Q45052723 | ||
| Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. | Q46067855 | ||
| Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis | Q46464268 | ||
| Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice. | Q46471398 | ||
| Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. | Q48024001 | ||
| The fibrosis marker galectin-3 and outcome in the general population | Q48821773 | ||
| Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice. | Q53319230 | ||
| 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. | Q54772288 | ||
| Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans | Q57984330 | ||
| Adipocyte death, adipose tissue remodeling, and obesity complications | Q81234708 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 310-319 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Obesity | Q15763232 |
| P1476 | title | Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function | |
| P478 | volume | 21 |
| Q64255883 | 3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet |
| Q37164707 | Adiponectin in inflammatory and immune-mediated diseases |
| Q90134675 | Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3 |
| Q43170207 | CILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators |
| Q50699513 | Combined inhibition of autophagy protein 5 and galectin-1 by thiodigalactoside reduces diet-induced obesity through induction of white fat browning. |
| Q38265267 | Detrimental and protective fat: body fat distribution and its relation to metabolic disease |
| Q50130176 | Downregulation of β1,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation. |
| Q92341061 | Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial |
| Q98566256 | Galectin-1 is inversely associated with type 2 diabetes independently of obesity - A SCAPIS pilot study |
| Q102152223 | Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis |
| Q38382993 | Galectin-3 inhibition prevents adipose tissue remodelling in obesity. |
| Q42624178 | Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets |
| Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q38942909 | Galectin-9: From cell biology to complex disease dynamics |
| Q64059939 | Galectins in the Pathogenesis of Cerebrovascular Accidents: An Overview |
| Q35061556 | Increased adiposity in annexin A1-deficient mice |
| Q34603941 | Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice |
| Q51311008 | Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor? |
| Q98611605 | Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men |
| Q55308149 | Mice lacking galectin-3 (Lgals3) function have decreased home cage movement. |
| Q37067301 | New pathways to control inflammatory responses in adipose tissue |
| Q33403525 | Obesity and IL-6 interact in modulating the response to endotoxemia in mice |
| Q35902394 | Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats |
| Q46298007 | Relationship of galectin-3 with obesity, IL-6, and CRP in women |
| Q34345441 | Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice |
| Q42827891 | Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats. |
| Q55349770 | The Role of Galectins as Modulators of Metabolism and Inflammation. |
| Q41532332 | iTRAQ-Based Quantitative Proteomics Analysis of the Protective Effect of Yinchenwuling Powder on Hyperlipidemic Rats. |
| Q38438717 | mRNA Transcriptomics of Galectins Unveils Heterogeneous Organization in Mouse and Human Brain |
Search more.